Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Gege Gui

Name: MRD as a clinical endpoint in trials for AML: updates from recent datasets
Uploaded: 2026-09-18T00:00:00Z
Duration: 14 min 4 s

PhD

Virginia Tech FBRI Cancer Center

Sorry, no posts matched your criteria.

Gege Gui

Cookie settings